Orange Book product · Brand (NDA)
SOMA
CARISOPRODOL
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CARISOPRODOL
Strength
250MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 011792
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —RELABrand (NDA)
NDA 012155 · SCHERING
- 2021CARISOPRODOLGeneric (ANDA)
ANDA 211789 · POINTVIEW HLDINGS
- 2017CARISOPRODOLGeneric (ANDA)
ANDA 207237 · MPP PHARMA
- 2016CARISOPRODOLGeneric (ANDA)
ANDA 040792 · AUROBINDO PHARMA
- 2015CARISOPRODOLGeneric (ANDA)
ANDA 205513 · STRIDES PHARMA
- 2015CARISOPRODOLGeneric (ANDA)
ANDA 205126 · HERITAGE
- 2014CARISOPRODOLGeneric (ANDA)
ANDA 090988 · NATCO
- 2014CARISOPRODOLGeneric (ANDA)
ANDA 205085 · ORIENT PHARMA CO LTD
- 2014CARISOPRODOLGeneric (ANDA)
ANDA 203374 · SCIEGEN PHARMS
- 2008CARISOPRODOLGeneric (ANDA)
ANDA 040823 · INGENUS PHARMS LLC
- 2007CARISOPRODOLGeneric (ANDA)
ANDA 040755 · SUN PHARM INDS LTD
- 2005CARISOPRODOLGeneric (ANDA)
ANDA 040576 · ACCELRX LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
